It was diverse, exciting and controversial – this year’s Skin Cancer Congress. The content ranged from hot topics, controversies in dermato-oncology and neoadjuvant therapy to rare skin tumors, side effect management and the availability of innovative therapies in oncology. In addition, interdisciplinary cooperation was given a large framework in order to generate the best possible treatment management for patients.
This content is machine-translated. Please contact us if you need professional translation services.
Autoren
- Leoni Burggraf
Publikation
- InFo ONKOLOGIE & HÄMATOLOGIE
Related Topics
You May Also Like
- Chronic urticaria
“Treat-to-target” approach is underpinned by new findings
- Dual GIP/GLP-1 RA in type 2 diabetes
Tirzepatide proves multiple benefits
- Pain syndrome
From pathophysiology to therapy – a reminder
- Sunscreen
Increasing risk of skin cancer due to dangerous UV radiation
- Coronary heart disease and type 2 diabetes
Relationship between baseline FFA values and all-cause mortality.
- Esophagus
Therapy of esophageal carcinoma – an overview
- Visceral Surgery Update - Part 1
Upper gastrointestinal tract and robotic visceral surgery
- Case reports: Pityriasis rubra pilaris (PRP)